Drug profile · INN
nalidixic acid
NALIDIXIC ACID
nalidixic acid (NALIDIXIC ACID) is a bacterial dna gyrase inhibitor. Route of administration: oral. Current US regulatory status: approved.
Drug details — nalidixic acid
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 1
- Data quality
- 0.84
Quick answer
nalidixic acid (NALIDIXIC ACID) is a bacterial dna gyrase inhibitor. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Bacterial DNA gyrase inhibitor
Primary target: Bacterial DNA gyrase
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is nalidixic acid?
nalidixic acid (NALIDIXIC ACID) is a bacterial dna gyrase inhibitor. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for nalidixic acid?
NALIDIXIC ACID is a marketed brand name for nalidixic acid. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of nalidixic acid?
nalidixic acid has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.